Press Releases
2006
 
 
   

Press Release's for 2006

   
Date Title

December 7 , 2006 BioMS Pivotal MS Trial Receives Sixth Positive Review From Data Safety Monitoring Board

December 4, 2006 BioMS Raises Additional $6.2 Million in Private Placement

November 24, 2006 BioMS Medical Announces Private Placement

November 23, 2006 BioMS Commences Enrolment in a Relapsing Remitting MS Trial

November 16, 2006 BioMS Announces Professor Hans-Peter Hartung as National Coordinator in Germany for Pivotal MS Trial

November 13, 2006 BioMS Medical Announces Third Quarter 2006 Results

November 3, 2006 BioMS to Present at The MS Society of Canada, Alberta Division’s AGM and The Rodman& Renshaw 8th Annual Healthcare Conference

November 2, 2006 BioMS Receives Additional Patent For MS Drug MBP8298 In The United States

October 24, 2006 BioMS Expands Pivotal MS Trial into the Baltic States

October 12, 2006 BioMS Medical Expands Pivotal Multiple Sclerosis Trial into Finland

October 3, 2006 BioMS to Present at SACHS Associates’ Investor Forum and Biocontact 2006

September 26, 2006 BioMS to Present at the 22nd Congress of the European Committee for Treatment and Research in MS (ECTRIMS)

September 22, 2006 BioMS Medical Announces Appointment to Board of Directors

September 15, 2006 BioMS Medical to Present at Pharma Finance 2006

September 7, 2006 BioMS Medical Expands Pivotal Multiple Sclerosis Trial into Spain and Germany

August 16, 2006 BioMS Pivotal MS Trial Receives Fifth Positive Review From Data Safety Monitoring Board

August 14, 2006 BioMS Medical Announces Second Quarter 2006 Results

August 11, 2006 BioMS Announces its Intention to Renew a Normal Course Issuer Bid

June 22, 2006 BioMS Expands Pivotal MS Trial Into The Netherlands

June 13, 2006 European Journal of Neurology Publishes MBP8298 Phase ll and Long-Term Follow-up Data

June 2, 2006 BioMS to Present at Federation of Clinical Immunology Societies 2006

June 1, 2006 BioMS completes $15 million private placement

May 26, 2006 BioMS Announces Private Placement

May 16, 2006 BioMS Receives Regulatory Approval for Phase ll Relapsing-Remitting MS Trial

May 15, 2006 2006 1st Quarter Interim Report

May 12, 2006 BioMS to Present at the Rodman & Renshaw 3rd Annual Global Healthcare Conference

May 10, 2006 BioMS Expands Pivotal MS Trial into Denmark

May 9, 2006 BioMS Reaches Milestone in Pivotal MS Trial

May 3, 2006 BioMS's Pivotal MS Trial Receives 4th Positive Review from Data Safety Monitoring Board

April 28, 2006 BioMS to Present at Biofinance 2006

April 26, 2006 BioMS to Present Clinical and Manufacturing Information at Tides® Conference

March 28, 2006 BioMS Announces Change of Auditor

March 13, 2006 BioMS Plans Relapsing-Remitting Multiple Sclerosis Trial

March 10, 2006 BioMS to Present at the Sachs Associates 5th Annual North America Forum

March 7, 2006 MBP8298 Shows 5 Year Delay of Disease Progression in Patients with MS

February 16, 2006 BioMS Medical Announces Year End 2005 Results

February 15, 2006 BioMS Medical Secures Long Term Manufacturing Agreements For MS Drug

February 9, 2006 BioMS Medical to Present at Bio CEO & Investor Conference

February 7, 2006 BioMS MS Trial Receives Third Positive Review From DSMB

January 26, 2006 BioMS Retains ICON For Pivotal MS Trial

January 25, 2006 BioMS to Present at Brean Murray Institutional Investor Conference

January 19, 2006 BioMS CEO Receives BioAlberta Award For Entrepreneurship

January 6, 2006 BioMS Medical Increases Equity Position in Drug Delivery Company
   
 
 
 
 
 
Copyright BioMS Medical 2008